PHC Holdings Corporation (6523) Stock Overview

PHC Holdings Corporation, through its subsidiaries, offers medical devices, healthcare IT solutions, and life science products and services primarily in Japan. It operates through Diabetes Management, Healthcare Solutions, and Diagnostic & Life Sciences segments. The company offers blood glucose monitoring systems, continuous glucose monitoring systems, and diabetes application; patient and record billing software, including electronic medical record system, electronic medication history system, and healthcare note service; and diagnostic testing products, which include clinical testing, diagnostic reagents and instruments, and drug development support products. It also provides biologic and cell preservation products, comprising low temperature freezers, CO2 incubators, and automatic tablet counting and packaging system; and cancer pathology products, which comprise tissue processor, microscopic slides, and cytology staining solutions. In addition, the company develops and produces precision medical devices that help with early detection and ongoing monitoring of diseases, such as diabetes and asthma, and drug delivery systems that support medical treatment. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. PHC Holdings Corporation was incorporated in 2013 and is headquartered in Tokyo, Japan.